Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

Inhibikase Therapeutics, Inc. Common Stock (IKT)
Inhibikase Therapeutics, Inc. Common Stock
XNAS:IKT
1.52
-1.30%

Ask
$1.69 - 100.00
Bid
$1.40 - 100.00
Low
$1.53
High
$1.61
Open
$1.56
Prev Close
$1.54
52W High
4.2
52W Low
1.33
Volume
252446
Avg Vol (3m)
525579.6
Float
85159386.95
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2836
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 12/23/2020
Primary Exchange: XNAS

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Phone: (302) 295-3800
Address: 1000 N. West Street, Suite 1200
City: Wilmington
State: DE
Postal Code: 19801
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
16
P/E (TTM)
-2.670000
P/B (TTM)
1.559820
EPS
-0.13
Round Lot
100
Composit FIGI
BBG005TP2339
Share Class FIGI
BBG005TP2348
Share Class Shares Outstanding
74.52M
Weighted Shares Outstanding
74.52M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own IKT. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.